TUESDAY, Nov. 25, 2025 (HealthDay News) — New clinical trial results bode well for what could be the first GLP-1 weight loss drug taken as a pill, not by injection. The daily pill, orforglipron, is currently under investigation by drugmaker Eli Lilly, which funded the study. In the 18-month trial,Continue Reading
TUESDAY, Nov. 25, 2025 (HealthDay News) — A large majority of Americans now view obesity as a disease whose management, surgical or pharmaceutical, should be covered by insurance, according to a new poll. The online Harris poll was conducted in October among nearly 4,200 U.S. adults. The study was supportedContinue Reading
TUESDAY, Nov. 25, 2025 (HealthDay News) — Researchers are standing behind new data on how people’s posteriors reflect changes linked to aging and diabetes. Shrinkage or inflammation of the gluteus maximus muscles of the buttocks may reflect frailty, sitting time, fat deposition and diabetes risk, and these changes may occurContinue Reading
TUESDAY, Nov. 25, 2025 (HealthDay News) — Fitter bodies and muscles could keep brains young and fit, too, a new study suggests. “Healthier bodies with more muscle mass and less hidden belly fat are more likely to have healthier, youthful brains,” said study senior author Dr. Cyrus Raji, associate professor ofContinue Reading
Its diabetes and weight loss drugs are driving the rapid growthContinue Reading
MONDAY, Nov. 24, 2025 (HealthDay News) — When it comes to warding off excess fat, boosting exercise levels while improving your diet may be most effective, rather than focusing on either exercise or diet alone. That’s the finding from a seven-year study of almost 7,300 British adults. “We found thatContinue Reading
FRIDAY, Nov. 21, 2025 (HealthDay News) — Obesity shouldn’t be considered a barrier for a patient who needs shoulder replacement surgery, a new study argues. In some places, doctors have been denying joint replacement surgery to people with a high body-mass index, due to concerns over their ability to recoverContinue Reading
WEDNESDAY, Nov. 19, 2025 (HealthDay News) — People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications. The company announced that through the end of March, patients with prescriptions can buy the twoContinue Reading
Immigration experts warn the policy could make it easier for officers to deny visas based on their own judgmentContinue Reading
The pricing applies to Medicare, Medicaid and a program launching later this year called TrumpRxContinue Reading